Company: LPSN
Filing Date: 2025-08-27
Form Type: PRE 14A
Source: 0001102993-25-000129
Chunk: 33

Company: LIVEPERSON INC
Filing Date: 2025-08-27
Form: PRE 14A
Chunk 33
---
, (iii) 2,439,870 shares of common stock under the Company’s Employee Stock Purchase Plan, (iv) 1,000,000 shares of our common stock subject to a stand-alone stock option award granted to our CEO, (v) [ ● ] shares of common stock issuable upon exchange of other outstanding options, (vi) [ ● ] shares issuable upon vesting of outstanding RSUs and performance-vesting RSUs (“PRSUs”), (vii) [ ● ] shares of common stock issuable upon exercise of outstanding warrants and (viii) [ ● ] shares of common stock issuable upon exercise of outstanding 2026 Notes (in each case, prior to giving effect to any change resulting from the Reverse Stock Split). The aggregate number of outstanding and reserved shares of common stock is [ ● ], prior to giving effect to any change resulting from the Reverse Stock Split.

On [ ● ], 2025 (the “Closing Date”), the Company consummated a privately negotiated exchange (the “Exchange”) with holders (the “Noteholders”) of approximately $341.1 million aggregate principal amount of our outstanding 0% Convertible Senior Notes due 2026 (the “2026 Notes”) of (x) such 2026 Notes for (y) (i) an aggregate payment of $45.0 million in cash, (ii) $115.0 million in aggregate principal amount of our 10.0% Second Lien Senior Subordinated Secured Notes due 2029, (iii) [ ● ] shares of common stock (such shares, the “Common Equity Shares”) and (iv) [ ● ] shares of Series B Preferred Stock.

The [ ● ] shares of Series B Preferred Stock are convertible into [ ● ] 1 shares of common stock. We seek authorization for our Board to amend our Charter to increase the number of Authorized Shares of Common Stock by a factor of 1.5x (the “Authorized Common Stock Increase”) to accommodate the conversion of the Series B Preferred Stock. See “Effects of Approving the Authorized Common Stock Increase Proposal” and “Effects of Not Approving the Authorized Common Stock Increase Proposal” below. Our Board has approved seeking stockholder authorization to effect the Authorized Common Stock Increase and recommends that our stockholders adopt and approve the

1 The [ ● ] shares of Series B Preferred Stock will be convertible into, together with the Common Equity Shares, an amount of shares of common stock equal to 39.0% (the “Aggregate